ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients

Endotheliopathy is suggested to be an important feature of COVID-19 in hospitalized patients. To determine whether endotheliopathy is involved in COVID-19-associated mortality, markers of endothelial damage were assessed in critically ill COVID-19 patients upon intensive care unit (ICU) admission. T...

Full description

Bibliographic Details
Main Authors: Alice G. Vassiliou, Chrysi Keskinidou, Edison Jahaj, Parisis Gallos, Ioanna Dimopoulou, Anastasia Kotanidou, Stylianos E. Orfanos
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/1/186
_version_ 1827599819143643136
author Alice G. Vassiliou
Chrysi Keskinidou
Edison Jahaj
Parisis Gallos
Ioanna Dimopoulou
Anastasia Kotanidou
Stylianos E. Orfanos
author_facet Alice G. Vassiliou
Chrysi Keskinidou
Edison Jahaj
Parisis Gallos
Ioanna Dimopoulou
Anastasia Kotanidou
Stylianos E. Orfanos
author_sort Alice G. Vassiliou
collection DOAJ
description Endotheliopathy is suggested to be an important feature of COVID-19 in hospitalized patients. To determine whether endotheliopathy is involved in COVID-19-associated mortality, markers of endothelial damage were assessed in critically ill COVID-19 patients upon intensive care unit (ICU) admission. Thirty-eight critically ill COVID-19 patients were included in this observational study, 10 of whom died in the ICU. Endothelial biomarkers, including soluble (s)E-selectin, sP-selectin, angiopoietin 1 and 2 (Ang-1 and Ang-2, respectively), soluble intercellular adhesion molecule 1 (sICAM-1), vascular endothelial growth factor (VEGF), soluble vascular endothelial (VE)-cadherin, and von Willebrand factor (vWf), were measured upon ICU admission. The ICU cohort was subsequently divided into survivors and non-survivors; Kaplan–Meier analysis was used to explore associations between biomarkers and survival, while receiver operating characteristic (ROC) curves were generated to determine their potential prognostic value. sE-selectin, sP-selectin, Ang-2, and sICAM-1 were significantly elevated in ICU non-survivors compared to survivors, and also associated with a higher mortality probability in the Kaplan–Meier analysis. The prognostic values of sE-selectin, Ang-2, and sICAM-1 from the generated ROC curves were greater than 0.85. Hence, we conclude that in our cohort, ICU non-survivors had higher levels of specific endothelial markers compared to survivors. Elevated levels of these markers upon ICU admission could possibly predict mortality in COVID-19.
first_indexed 2024-03-09T04:22:36Z
format Article
id doaj.art-11554e76f5fa4dfdb217fc710f4bfdaf
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T04:22:36Z
publishDate 2021-01-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-11554e76f5fa4dfdb217fc710f4bfdaf2023-12-03T13:44:51ZengMDPI AGCells2073-44092021-01-0110118610.3390/cells10010186ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 PatientsAlice G. Vassiliou0Chrysi Keskinidou1Edison Jahaj2Parisis Gallos3Ioanna Dimopoulou4Anastasia Kotanidou5Stylianos E. Orfanos6First Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 10675 Athens, GreeceFirst Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 10675 Athens, GreeceFirst Department of Critical Care Medicine & Pulmonary Services, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 10676 Athens, GreeceHealth Informatics Laboratory, School of Health Sciences, National and Kapodistrian University of Athens, 11527 Athens, GreeceFirst Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 10675 Athens, GreeceFirst Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 10675 Athens, GreeceFirst Department of Critical Care Medicine & Pulmonary Services, GP Livanos and M Simou Laboratories, School of Medicine, National and Kapodistrian University of Athens, Evangelismos Hospital, 10675 Athens, GreeceEndotheliopathy is suggested to be an important feature of COVID-19 in hospitalized patients. To determine whether endotheliopathy is involved in COVID-19-associated mortality, markers of endothelial damage were assessed in critically ill COVID-19 patients upon intensive care unit (ICU) admission. Thirty-eight critically ill COVID-19 patients were included in this observational study, 10 of whom died in the ICU. Endothelial biomarkers, including soluble (s)E-selectin, sP-selectin, angiopoietin 1 and 2 (Ang-1 and Ang-2, respectively), soluble intercellular adhesion molecule 1 (sICAM-1), vascular endothelial growth factor (VEGF), soluble vascular endothelial (VE)-cadherin, and von Willebrand factor (vWf), were measured upon ICU admission. The ICU cohort was subsequently divided into survivors and non-survivors; Kaplan–Meier analysis was used to explore associations between biomarkers and survival, while receiver operating characteristic (ROC) curves were generated to determine their potential prognostic value. sE-selectin, sP-selectin, Ang-2, and sICAM-1 were significantly elevated in ICU non-survivors compared to survivors, and also associated with a higher mortality probability in the Kaplan–Meier analysis. The prognostic values of sE-selectin, Ang-2, and sICAM-1 from the generated ROC curves were greater than 0.85. Hence, we conclude that in our cohort, ICU non-survivors had higher levels of specific endothelial markers compared to survivors. Elevated levels of these markers upon ICU admission could possibly predict mortality in COVID-19.https://www.mdpi.com/2073-4409/10/1/186endotheliopathyCOVID-19sE-selectinsP-selectinangiopoietinsICAM-1
spellingShingle Alice G. Vassiliou
Chrysi Keskinidou
Edison Jahaj
Parisis Gallos
Ioanna Dimopoulou
Anastasia Kotanidou
Stylianos E. Orfanos
ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
Cells
endotheliopathy
COVID-19
sE-selectin
sP-selectin
angiopoietin
sICAM-1
title ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
title_full ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
title_fullStr ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
title_full_unstemmed ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
title_short ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients
title_sort icu admission levels of endothelial biomarkers as predictors of mortality in critically ill covid 19 patients
topic endotheliopathy
COVID-19
sE-selectin
sP-selectin
angiopoietin
sICAM-1
url https://www.mdpi.com/2073-4409/10/1/186
work_keys_str_mv AT alicegvassiliou icuadmissionlevelsofendothelialbiomarkersaspredictorsofmortalityincriticallyillcovid19patients
AT chrysikeskinidou icuadmissionlevelsofendothelialbiomarkersaspredictorsofmortalityincriticallyillcovid19patients
AT edisonjahaj icuadmissionlevelsofendothelialbiomarkersaspredictorsofmortalityincriticallyillcovid19patients
AT parisisgallos icuadmissionlevelsofendothelialbiomarkersaspredictorsofmortalityincriticallyillcovid19patients
AT ioannadimopoulou icuadmissionlevelsofendothelialbiomarkersaspredictorsofmortalityincriticallyillcovid19patients
AT anastasiakotanidou icuadmissionlevelsofendothelialbiomarkersaspredictorsofmortalityincriticallyillcovid19patients
AT stylianoseorfanos icuadmissionlevelsofendothelialbiomarkersaspredictorsofmortalityincriticallyillcovid19patients